The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Obesity Management of Liver Transplant Waitlist Candidates and Recipients
Clin Liver Dis. 2021 Feb;25(1):1-18. doi: 10.1016/j.cld.2020.08.001.Epub 2020 Oct 12.
Danielle Brandman1
Author information
1Department of Medicine, Division of Gastroenterology, University of California San Francisco, 513 Parnassus Avenue, Box 0538, Room S357, San Francisco, CA 94143, USA. Electronic address: Danielle.brandman@ucsf.edu.
Abstract
Obesity is increasing in prevalence in liver transplant candidates and recipients. The rise in liver transplantation for nonalcoholic steatohepatitis reflects this increase. Management of obesity in liver transplant candidates can be challenging due to the presence of decompensated cirrhosis and sarcopenia. Obesity may increase peritransplant morbidity but does not have an impact on long-term post-transplant survival. Bariatric surgery may be a feasible option in select patients before, during, or after liver transplantation. Use of weight loss drugs and/or endoscopic therapies for obesity management ultimately may play a role in liver transplant patients, but more research is needed to determine safety.